Following a reverse share split, Cybin Inc. (NYSE American: CYBN) updated investors on the company’s pipeline. Share consolidation On Thursday, Cybin completed its share consolidation to reduce the number of outstanding shares and drive the value per share higher. Shareholders had approved a consolidation as high as one share for …
The Daily Hit is a recap of the top financial news stories for Wednesday, September 18, 2024. On the Site Missouri issues yet another cannabis recall, rolls back hemp ban The state’s Department of Health and Senior Services will focus its efforts on “misbranded” products rather than intoxicating ones. Read …
A European citizens’ initiative aimed at promoting psychedelic-assisted treatments for mental health disorders has been registered by the European Commission. The initiative, dubbed “PsychedeliCare,” was registered on Sept. 11, according to the European Commission’s official website, in a bid to establish a transnational legal framework around psychedelic therapy in the …
Psyence Biomedical Ltd (Nasdaq: PBM) is poised to hit several psilocybin-related “milestones” in coming months, including the acquisition of drug developer Clairvoyant, the launch of research into psilocybin as a treatment for substance use disorders and ongoing clinical trials in Australia for psilocybin in treating adjustment disorder. CEO Dr. Neil …